Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | METAP2 | P50579 | 1/20 | 0.34 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.32 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.32 |
| ▸ | RXRA | P19793 | 1/20 | 0.32 |
| ▸ | RXRB | P28702 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | TSPO | P30536 | 2/20 | 0.31 |
| ▸ | MAT2A | P31153 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18561158 | 0.96 | L3MBTL1 (0.43) | L3MBTL1KDM4EATMMETAP2HDAC4 | |
| SCHEMBL17040873 | 0.95 | L3MBTL1 (0.44) | L3MBTL1KDM4EATMMETAP2HDAC4 | |
| SCHEMBL17056481 | 0.95 | L3MBTL1 (0.49) | L3MBTL1KDM4EATMMETAP2HDAC4 | |
| SCHEMBL30096021 | 0.95 | L3MBTL1 (0.49) | L3MBTL1KDM4EATMMETAP2HDAC4 | |
| SCHEMBL17040894 | 0.94 | KDM4E (0.40) | L3MBTL1KDM4EATMMETAP2HDAC4 | |
| SCHEMBL17040868 | 0.93 | L3MBTL1 (0.40) | L3MBTL1KDM4EATMMETAP2HDAC4 | |
| SCHEMBL17040872 | 0.92 | ATM (0.36) | L3MBTL1KDM4EATMMETAP2KMT2A | |
| SCHEMBL19738248 | 0.92 | L3MBTL1 (0.46) | L3MBTL1KDM4EATMMETAP2HDAC4 | |
| SCHEMBL16749671 | 0.92 | L3MBTL1 (0.46) | L3MBTL1KDM4EATMHDAC4KMT2A | |
| SCHEMBL17040891 | 0.92 | L3MBTL1 (0.41) | L3MBTL1KDM4EATMHDAC4KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10700285-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2020-06-30 | — | — | US | disclosed |
| US-20170062728-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2017-03-02 | — | — | US | disclosed |
| US-20170062728-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2017-03-02 | — | — | US | disclosed |
| WO-2015126090-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME AND ELECTRONIC DEVICE THEREOF | 덕산네오룩스 주식회사 | 2015-08-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170062728-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | GPX1, OR51E2, PIEZO1 | L3MBTL1 297/4885KDM4E 984/4885ATM 4174/4885 |
| US-10700285-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | GPX1, OR51E2, PIEZO1 | L3MBTL1 297/4885KDM4E 984/4885ATM 4174/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.